Abstract
Study design: Hospital based observational study.
Objectives: To evaluate the role of methyl prednisolone (MPS) in the management of acute transverse myelitis (ATM).
Methods: Twenty-one patients with ATM were included in a prospective hospital based study during 1992–1997. All the patients underwent neurological examination, spinal MRI, somatosensory and motor evoked potentials of both upper and lower limbs and concentric needle EMG study. Twelve consecutive patients did not receive MPS therapy who were managed during 1992–1994 and nine consecutive patients during 1995–1997 received MPS therapy in a dose of 500 mg i.v. for 5 days. The clinical and neurophysiological studies were repeated 3 months later. The outcome was defined on the basis of Barthel index (BI) score at the end of 3 months into good (BI⩾12) and poor (BI<12).
Results: The age of MPS group was 25.5 years (range 12–42) and three were females. The age of non MPS group was 33.5 years (range 16–70) and two were females. In the MPS group 33% had poor outcome compared to 67% in the non MPS group. In the MPS group mean admission BI score was 7.3 which improved to 14.6 after MPS therapy. In the non MPS group, the admission BI score was 3.2 which improved to 9.6 at 3 month follow-up. In patients with complete paraplegia, evidence of denervation on EMG and unrecordable central motor conduction time to lower limb and tibial SEP were associated with poor outcome irrespective of MPS treatment. Global test statistics did not suggest a beneficial role of MPS therapy in the outcome of ATM.
Conclusion: Our results do not suggest a beneficial role of methyl prednisolone on the 3 month outcome of ATM.
Spinal Cord (2001) 39, 471–476.
Similar content being viewed by others
Article PDF
References
Abramsky O, Teitelbaum D . The autoimmune features of acute transverse myelopathy Ann Neurol 1977 2: 36
Dowling PC, Bosch VV, Cook SD . Possible beneficial effect of high dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis Neurology 1980 30: 33–36
Sebire G et al. High dose methyl prednisolone in severe acute transverse myelopathy Arch Dis Child 1997 77: 167–168
Miller HG, Gibbons JL . Acute disseminated sclerosis: results of treatment with ACTH Br Med J 1953 2: 1345–1348
Barnes MP et al. Intravenous methyl prednisolone for multiple sclerosis in relapse J Neurol Neurosurg Psychiat 1985 48: 157–159
Lopez Dupla M et al. Transverse myelitis as a first manifestation of systemic lupus erythematosus: A case report Lupus 1995 4: 239–242
Milligan NM, Newcombe R, Compston DA . A double blind controlled trial of high dose methyl prednisolone in patients with multiple sclerosis. 1. Clinical effects J Neurol Neurosurg Psychiat 1987 50: 511–516
Kalita J, Gupta PM, Misra UK . Clinical and evoked potential changes in acute transverse myelitis following methyl prednisolone Spinal Cord 1999 37: 658–662
Jaffery DR, Mandler RL, Davis L . Transverse myelitis retrospective analysis of 33 cases with differentiation of cases associated with multiple sclerosis and parainfectious events Arch Neurol 1993 50: 532–535
Penn RD et al. Intrathecal baclofen for severe spinal spasticity N Engl J Med 1989 320: 1517–1521
Misra UK, Kalita J, Kumar S . A clinical, MRI and neurophysiological study of acute transverse myelitis J Neurol Sci 1996 138: 150–156
Misra UK, Kalita J . Motor evoked potentials is useful in monitoring the effect of coller therapy J Neurol Sci 1998 154: 222–228
Kalita J, Misra UK . Motor and somatosensory evoked potentials in tuberculous meningitis: A clinicoradiological correlation Acta Neurol Scand 1999 99: 225–231
O'Brien PC . Procedures for comparing samples with multiple end points Biometrics 1984 40: 1079–1089
Pandit L, Rao S . Recurrent myelitis J Neurol Neurosurg Psychiat 1996 60: 336–338
Baca V et al. Successful treatment of transverse myelitis in a child with systemic lupus erythematosus Neuropediatrics 1996 27: 42–44
Chan KF, Boey ML . Transverse myelopathy in SLE. Clinical features and functional outcome Lupus 1996 5: 294–299
Hoffman HL . Acute necrotic myelopathy Brain 1955 78: 377–393
Misra UK, Kalita J . Can electromyography predict the prognosis of transverse myelitis J Neurol 1998 25: 741–744
Ellison GW, Mickey MR, Kyers LW . Alternatives to randomised clinical trials Neurology 1988 38: suppl 2 73–75
Acknowledgements
We thank Dr SK Mandal, Scientist, Central Drug Research Institute, Lucknow for statistical analysis, Mr SP Singh and Mr Rakesh Kumar Nigam for technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalita, J., Misra, U. Is methyl prednisolone useful in acute transverse myelitis?. Spinal Cord 39, 471–476 (2001). https://doi.org/10.1038/sj.sc.3101190
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.sc.3101190
Keywords
This article is cited by
-
High-dose corticosteroids for acute cytomegalovirus-associated transverse myelitis in the immunocompetent patient: a case report and systematic review
Journal of NeuroVirology (2019)
-
Acute demyelinating disorders of the central nervous system
Current Treatment Options in Neurology (2009)
-
Demyelinating disorders: Update on transverse myelitis
Current Neurology and Neuroscience Reports (2006)
-
Encephalomyelitis following mumps
Spinal Cord (2005)
-
Akute Myelitis bei Neurolisteriose
Der Nervenarzt (2005)